BACKGROUND: Despite the advances in the multidisciplinary treatment of gastric adenocarcinoma, the overall 5-year survival remains only 33.3% in North America. R0 resection with adequate lymphadenectomy remains the mainstay therapy…
BACKGROUND: Endoscopic submucosal dissection (ESD) of colorectal lesions is technically demanding and carries a significant rate of noncurative resection…
INTRODUCTION: The main treatment options for cholestasis in advanced pancreas cancer are endoscopic stenting (ES), transhepatic drainage, and biliary bypass surgery (BBS). The aim of the current study is to compare the safety and efficacy of BBS and ES…
BACKGROUND: Siewert's topographic classification (SW) has been used for treatment plan of esophagogastric junction adenocarcinomas (EGJA). But recently, molecular classifications categorized EGJA with similar characteristics and prognosis…